During the past decade, Centro Hospitalar do Funchal conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Hospitalar do Funchal" are "Colorectal Carcinoma" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Centro Hospitalar do Funchal" in a lesser frequency.

Most popular intervention types in "Centro Hospitalar do Funchal" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab" (1 trials), "Pulmonary function Testing" (1 trials) and "tiotropium bromide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hospitalar do Funchal" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Hospitalar do Funchal". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Hospitalar do Funchal, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hospitalar do Funchal, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".